281 – 290 of 354
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2000
-
Mark
Human glandular kallikrein 2: a potential serum marker for predicting the organ confined versus non-organ confined growth of prostate cancer
(
- Contribution to journal › Article
-
Mark
Discrimination of men with prostate cancer from those with benign disease by measurements of human glandular kallikrein 2 (HK2) in serum
(
- Contribution to journal › Article
-
Mark
Time-resolved fluorometry in end-point and real-time PCR quantification of nucleic acids
(
- Contribution to journal › Article
-
Mark
Enzymatic action of prostate-specific antigen (PSA or hK3) : Substrate specificity and regulation by Zn2+, a tight-binding inhibitor
(
- Contribution to journal › Article
-
Mark
Production and characterization of novel anti-prostate-specific antigen (PSA) monoclonal antibodies that do not detect internally cleaved Lys145-Lys146 inactive PSA
(
- Contribution to journal › Article
-
Mark
New nomenclature for the human tissue kallikrein gene family
(
- Contribution to journal › Article
-
Mark
Streptavidin-polyvinylamine conjugates labeled with a europium chelate : Applications in immunoassay, immunohistochemistry, and microarrays
(
- Contribution to journal › Article
- 1999
-
Mark
Early Diagnosis and Staging.
(
- Contribution to journal › Article
-
Mark
Diagnostic value of percent free prostate-specific antigen: retrospective analysis of a population-based screening study with emphasis on men with PSA levels less than 3.0 ng/mL
(
- Contribution to journal › Article
-
Mark
The proportion of carboxylated to total or intact osteocalcin in serum discriminates warfarin-treated patients from control subjects
(
- Contribution to journal › Article